Although these medications contain the same active ingredient, their approved indications and dosing differ based on formulation and strength
In stark contrast, dietary supplements marketed as "GLP-1" products are regulated under the Dietary Supplement Health and Education Act (DSHEA) of 1994, which places the burden of safety on manufacturers rather than requiring pre-market approval
It is important to note that the apparent magnitude of the weight-loss effect is often influenced by baseline levels, control conditions, and follow-up windows
Depending on your dosage, you might not use up the whole pen by the expiration date (and thus would be wasting leftover medication)
In this context, it has been demonstrated that treatments with either a GLP1/Estrogen (GLP1/E) conjugate, a unimolecular GLP1/GIP (gastric inhibitory peptide) dual agonist, or a GLP1/GIP/Glucagon triagonist, markedly reduced body weight and improved diabetic complications, including hyperinsulinemia, in preclinical models of obesity in males 33,34,35